These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 30738642)
21. AIP1 suppresses atherosclerosis by limiting hyperlipidemia-induced inflammation and vascular endothelial dysfunction. Huang Q; Qin L; Dai S; Zhang H; Pasula S; Zhou H; Chen H; Min W Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):795-804. PubMed ID: 23413429 [TBL] [Abstract][Full Text] [Related]
22. Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR Thompson D; Morrice N; Grant L; Le Sommer S; Lees EK; Mody N; Wilson HM; Delibegovic M Clin Sci (Lond); 2017 Oct; 131(20):2489-2501. PubMed ID: 28899902 [TBL] [Abstract][Full Text] [Related]
23. Group 1B phospholipase A₂ inactivation suppresses atherosclerosis and metabolic diseases in LDL receptor-deficient mice. Hollie NI; Konaniah ES; Goodin C; Hui DY Atherosclerosis; 2014 Jun; 234(2):377-80. PubMed ID: 24747111 [TBL] [Abstract][Full Text] [Related]
25. Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient mice. Mullick AE; Fu W; Graham MJ; Lee RG; Witchell D; Bell TA; Whipple CP; Crooke RM J Lipid Res; 2011 May; 52(5):885-96. PubMed ID: 21343632 [TBL] [Abstract][Full Text] [Related]
26. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice. Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172 [TBL] [Abstract][Full Text] [Related]
27. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice. Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220 [TBL] [Abstract][Full Text] [Related]
28. Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R-/-) Mice. Feuerborn R; Besser M; Potì F; Burkhardt R; Weißen-Plenz G; Ceglarek U; Simoni M; Proia RL; Freise H; Nofer JR Thromb Haemost; 2018 Aug; 118(8):1470-1480. PubMed ID: 30060257 [TBL] [Abstract][Full Text] [Related]
31. Anti-atherogenic effect of BHB-TZD having inhibitory activities on cyclooxygenase and 5-lipoxygenase in hyperlipidemic mice. Choi JH; Jeon HJ; Park JG; Sonn SK; Lee MR; Lee MN; You HJ; Kim GY; Kim JH; Lee MH; Kwon OS; Nam KH; Kim HC; Jeong TS; Lee WS; Oh GT Atherosclerosis; 2010 Sep; 212(1):146-52. PubMed ID: 20684827 [TBL] [Abstract][Full Text] [Related]
32. Clearing the Clutter: Antiatherosclerotic activity of Eucalyptus camaldulensis crude extract. -Ain QU; Ahmed A; Nisa Iqbal MU; Hashmi IA; Khan NI; Khan TA Pak J Pharm Sci; 2021 Nov; 34(6):2205-2211. PubMed ID: 35034882 [TBL] [Abstract][Full Text] [Related]
33. Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice. Song G; Tian H; Qin S; Sun X; Yao S; Zong C; Luo Y; Liu J; Yu Y; Sang H; Wang X Atherosclerosis; 2012 Mar; 221(1):55-65. PubMed ID: 22209213 [TBL] [Abstract][Full Text] [Related]